paid-only post Nov 11, 2025 activistcompany BML Capital condemns Adverum Biotechnologies, Inc (ADVM) merger with Eli Lilly as flawed and value-destructive This post is for paying subscribers only Subscribe to continue reading Subscribe now Already have an account? Sign in
Liberty 77 Capital entered into a governance and standstill agreement with Lionsgate Studios Corp. (LION) 28 Jan
Endeavor Group Responds to Mawson Infrastructure Group’s (MIGI) Adoption of Stockholder Rights Plan 23 Jan
Friedland Enterprises calls for governance overhaul and strategic review at Lulu's Fashion Lounge Holdings, Inc. (LVLU) 12 Jan